Purchase Order 75N93021P01223
Award Date 8/24/21
Potential Completion Date 8/24/22
Potential Value $101K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the purchase of NextSeq, MiSeq, and iSeq sequencing kits. The $96,390.00 award does not have a set-aside designation and is intended to support genomic research and analysis at the agency's Bethesda, MD location. Illumina has...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract is for the purchase of NextSeq 1000/2000 and MiSeq reagent kits, valued at $109,656.60. The order supports the agency's Coronavirus COVID-19 response efforts. The contract is awarded on a firm fixed-price basis with no set-aside...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. to provide an Illumina NextSeq 550 sequencing system. The potential value of the contract is $273,655.08. There was no set-aside designation for this award. Illumina, a for-profit manufacturer of genetic and genomic analysis instruments and reagents, has provided a range of sequencing systems and related...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 Sequencing System or equal, valued at $239,700.00. The requirement was issued through a commercial items solicitation using Simplified Acquisition Procedures, with no set-aside designation. The sequencing system is intended to support the increased workload at the Center for Human Immunology,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic analysis products, to provide TruSeq and MiSeq sequencing kits. The $10,176.95 award supports the agency's research and diagnostics needs, and follows previous prime contract awards to Illumina under which the company has supplied sequencing systems, reagents, and...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $4,037.50, is for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, and support services. The contract has no set-aside designation....
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $953,700.00 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer, to provide a NOVASEQ 6000 sequencing system. The contract has no set-aside designation and was completed on September 29, 2017. Illumina has previously received prime contracts from various federal agencies, including the NIH, CDC, USDA, and VA, to supply...
- This is a $6,935.22 firm fixed-price purchase order contract awarded to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH). The contract, which has no set-aside designation, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies. Illumina has...
- The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for the NextSeq 1000 Sequencing System. The $213,150.00 contract supports NIAID's Vaccine Immunology Program's research into monoclonal antibodies and vaccines for infectious diseases such as HIV, influenza, Ebola, and SARS-CoV-2....
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $53,029.50 firm-fixed price purchase order to Illumina, Inc. for a one-year service plan covering preventative maintenance, full parts and labor coverage, reagent replacement, remote technical support, and software/hardware updates for the agency's Illumina NextSeq 2000 sequencing equipment at their Laboratory of Viral Diseases. This purchase was made under full and...